Business Wire

OTREXUP ™ (methotrexate) Injection Approved By FDA a New Treatment for Adults with Rheumatoid Arthritis, Children with Polyarticular Idiopathic Arthritis, and Adults with ...

EWING, N.J.-- (BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of OTREXUP ™ (methotrexate) injection by the U.S. Food and Drug Administration (FDA). OTREXUP ™ is the ...
equities

FDA Approves Antares Pharma’s Otrexup for Arthritis and Psoriasis

Shares of self injection drug delivery technology company Antares Pharma, Inc. (ATRS) are trading higher on Monday after the U.S. Food and Drug Administration approved Otrexup, a once-per-week ...
Business Wire

Antares Pharma Announces the Issuance of a New U. S. Patent for OTREXUP™

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received a Notice of Issuance from the U. S. Patent Office for patent number 8,480,631 entitled “Hazardous ...
Pharmabiz

Antares Pharm's Otrexup receives additional US patent coverage

Antares Pharma, Inc., a company focuses on self-administered parenteral pharmaceutical products, has received US Patents RE 44846 and RE 44847. These patents are reissued versions of US Patents ...